Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.
Department of Biomedical Informatics, CHA University School of Medicine, Seongnam, South Korea.
Cardiovasc Diabetol. 2023 Mar 28;22(1):71. doi: 10.1186/s12933-023-01805-8.
High-density lipoprotein cholesterol's (HDL-C) long-held status as a cardiovascular disease (CVD) preventative has been called into question. Most of the evidence, however, focused on either the risk of death from CVD, or on single time point level of HDL-C. This study aimed to determine the association between changes in HDL-C levels and incident CVD in individuals with high baseline HDL-C levels (≥ 60 mg/dL).
77,134 people from the Korea National Health Insurance Service-Health Screening Cohort were followed for 517,515 person-years. Cox proportional hazards regression was used to evaluate the association between change in HDL-C levels and the risk of incident CVD. All participants were followed up until 31 December 2019, CVD, or death.
Participants with the greatest increase in their HDL-C levels had higher risks of CVD (adjusted hazard ratio [aHR], 1.15; 95% confidence interval [CI], 1.05-1.25) and CHD (aHR 1.27, CI 1.11-1.46) after adjusting for age, sex, household income, body mass index, hypertension, diabetes mellitus, dyslipidemia, smoking, alcohol consumption, moderate-to-vigorous physical activity, Charlson comorbidity index, and total cholesterol than those with the lowest increase in HDL-C levels. Such association remained significant even among participants with decreased low-density lipoprotein cholesterol (LDL-C) levels for CHD (aHR 1.26, CI 1.03-1.53).
In people with already high HDL-C levels, additional increases in HDL-C levels may be associated with an increased risk of CVD. This finding held true irrespective of the change in their LDL-C levels. Increasing HDL-C levels may lead to unintentionally elevated risk of CVD.
高密度脂蛋白胆固醇(HDL-C)作为心血管疾病(CVD)预防因子的长期地位受到质疑。然而,大多数证据要么关注 CVD 死亡风险,要么关注 HDL-C 的单一时间点水平。本研究旨在确定基线 HDL-C 水平较高(≥60mg/dL)的个体中 HDL-C 水平变化与 CVD 事件之间的关联。
对韩国国家健康保险服务-健康筛查队列中的 77134 人进行了 517515 人年的随访。采用 Cox 比例风险回归评估 HDL-C 水平变化与 CVD 事件风险之间的关系。所有参与者均随访至 2019 年 12 月 31 日、CVD 或死亡。
调整年龄、性别、家庭收入、体重指数、高血压、糖尿病、血脂异常、吸烟、饮酒、中高强度体力活动、Charlson 合并症指数和总胆固醇后,与 HDL-C 水平最低升高组相比,HDL-C 水平升高幅度最大的患者发生 CVD(调整后的危险比[aHR],1.15;95%置信区间[CI],1.05-1.25)和冠心病(aHR 1.27,CI 1.11-1.46)的风险更高。即使在 LDL-C 水平降低的冠心病患者中,这种关联仍然显著(aHR 1.26,CI 1.03-1.53)。
在 HDL-C 水平已经较高的人群中,HDL-C 水平的进一步升高可能与 CVD 风险增加相关。无论 LDL-C 水平的变化如何,这一发现都是成立的。增加 HDL-C 水平可能会导致 CVD 风险意外升高。